Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases
Partnership grants Ignaz Semmelweis Institute access to Nona's H2L2 Harbour Mice® transgenic mouse technology platform for translational antibody research CAMBRIDGE, Mass., July 23, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global...